ArticleJournal of experimental & clinical cancer research : CR2024

The G Protein Estrogen Receptor (GPER) is involved in the resistance to the CDK4/6 inhibitor palbociclib in breast cancer.

Marianna Talia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.